Advertisement

Delivery Systems and Research for Schizophrenia in China

  • Zhang Mingdao
  • Xia Zhenyi
Chapter
  • 80 Downloads
Part of the International Perspectives Series: Psychiatry, Psychology, and Neuroscience book series

Abstract

China is a multinationality country with a total population of 1 billion. Administratively it has 23 provinces, 5 autonomous regions, and 3 municipalities directly under the central government

Keywords

Mental Health Mental Health Service Schizophrenic Patient Psychiatric Hospital Tardive Dyskinesia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Chen CG, Zhang WX, Shen YC: Data analysis of an epidemiological study on mental disorders, drug and alcoholic dependencies, and personality disorders. Chinese J Neurol Psychiat 1986;19:70–71.Google Scholar
  2. 2.
    Chen CG, Zhang WX, Shen YC: Analysis of epidemiological data of schizophrenia. Chinese J Neurol Psychiat 1986;19:73–76.Google Scholar
  3. 3.
    CMA: The clinical working diagnostic criteria of schizophrenia. Chinese J Neurol Psychiat 1985;18:317.Google Scholar
  4. 4.
    Jia YC, Shu ZH: Chlorpromazine treatment in mental disorders. Chinese J Neurol Psychiat 1956;2:89–100.Google Scholar
  5. 5.
    Da ZM, Gu NF, Bo SK, et al: The prescribing trend of psychotropic medication during the past 10 years as observed at the SMHC. Shanghai Arch Psychiat 1988;6:1–4.Google Scholar
  6. 6.
    Yan HQ, Xu, SH: Traditional Chinese medicine and psychiatryGoogle Scholar
  7. 7.
    Xia ZY, Zhang MY: History and present status of modern psychiatry in China. Chinese Med J 1981;94:277–282.Google Scholar
  8. 8.
    Xia ZY: The mental health delivery system in Shanghai, in Tseng WS (ed): Chinese Culture and Mental Health. Orlando, FL Academic Press, Inc, 1985, pp 341–355.Google Scholar
  9. 9.
    SMHC/MPH: Proceedings of The Second National Conference on Mental Health Services, China. 1986, unpublished.Google Scholar
  10. 10.
    Lin TY: The shaping of Chinese psychiatry in the content of politics and public health, in Lin TY, Eisenberg L (eds): Mental Health Planning for One Billion People. A Chinese Perspective. Vancouver, UBC Press, 1985, pp 3–37.Google Scholar
  11. 11.
    The Ministry of Public Health, PRC: A brief introduction on China’s medical and health services. China. 1986, unpublished.Google Scholar
  12. 12.
    Ji M, Xu JJ, Xia ZY, et al: Genetic investigation on 1196 cases of schizophrenia in Shanghai. Chinese J Neurol Psychiat 1964;8:80–81.Google Scholar
  13. 13.
    Zhu XX, Yao JX, Yang JF, et al: Heredofamilial analysis of 2,000 cases of schizophrenic inpatients. Chinese J Nerv Ment Dis 1978;4:254–255.Google Scholar
  14. 14.
    Lei S: Heredofamilial and treatment effectiveness investigation on 1932 cases of schizophrenia. Chinese J Nerv Ment Dis 1983;9:5.Google Scholar
  15. 15.
    Wang TX, Wang M, Yang KY, et al: Nonmatched pedigree investigation on 150 schizophrenics. Chinese J Nerv Ment Dis 1985;11:269–271.Google Scholar
  16. 16.
    Lou HM, Wu YB, Zhao YZ. An investigation of the heritability of schizophrenia in northeast China. Chinese J Neurol Psychiat 1983;16:49–50.Google Scholar
  17. 17.
    Xia ZY, Giang SD, Bei GP et al: Genetic factors and mode of inheritance in childhood schizophrenia. Chinese J Nerv Ment Dis 1982;8:18–21.Google Scholar
  18. 18.
    Wang WY, Yu DS, Zhe ST: The clinical symptomatological concordance in the first degree relatives of schizophrenic patients. Chinese J Neurol Psychiat 1987;20:219–220.Google Scholar
  19. 19.
    Gang YQ: Difference in the familial and kinsfolk morbidity of schizophrenia among different nationalities. Chinese J Neurol Psychiat 1987;20:95–96.Google Scholar
  20. 20.
    Fang HT, Giang SD, Li CF, et al: Preliminary report on schizophrenic twins. Chinese J Nerv Ment Dis 1980;6:216–220.Google Scholar
  21. 21.
    Bei GP, Ling ZG, Fong GQ: A study of genetic marker in a schizophrenic twin pedigree. Chinese J Nerv Ment Dis 1983;9:30–31.Google Scholar
  22. 22.
    Deng ZY, Wu LX, Wang YG: A case report on concordance of monozygotic twins. Chinese J Neurol Psychiat 1987;20:191.Google Scholar
  23. 23.
    Gottesman I, Shields J (eds): Schizophrenia and Genetics. A Twin Study Vantage Point. New York, Academic Press, 1972, pp 51–68.Google Scholar
  24. 24.
    Fang HT, Ling ZG, Li CF, et al: A report of triplet siblings all suffering from schizophrenia. Chinese J Neurol Psychiat 1982;15:49–50.Google Scholar
  25. 25.
    Zha FS: A preliminary report of study on schizophrenia in adopted children. Chinese J Nerv Ment Dis 1984;10:32–34.Google Scholar
  26. 26.
    Luo KL: A study on 31 cases of schizophrenic adoptees. Chinese J Neurol Psychiat 1986;19:32–33.Google Scholar
  27. 27.
    Hong ML, Mei ZY, Tan Y, et al: Cytogenetic changes in 48 cases of schizophrenia. Chinese J Neurol Psychiat 1986;19:188–191.Google Scholar
  28. 28.
    Axelsson R, Wahlstrom J: Mental disorder and inversion on chromosome 9. Hereditas 1981;95:337.PubMedCrossRefGoogle Scholar
  29. 29.
    Zhang ZL, Shen WJ, Chen YM: Preliminary study of SCE frequency in the patients with schizophrenia. Chinese J Nerv Ment Dis 1986;12:292–293.Google Scholar
  30. 30.
    Crosses PE, Morgan WF: The effect of chlorpromazine on SCE frequency in human chromosomes. Mutation Research 1982;96:225–232.CrossRefGoogle Scholar
  31. 31.
    Chen YF, Shen YC, Li XX, et al: Changes of the levels of CSF monoamine metabolites in 102 chronic schizophrenic patients following probenecid before and after neuroleptic medication. Chinese J Neurol Psychiat 1984; 17: 273–277.Google Scholar
  32. 32.
    Zhang WH, Shu L, Shen YC: Metabolism of 5-hydroxytryptamine in schizophrenia. Chinese J Neurol Psychiat 1978;11:45–49.Google Scholar
  33. 33.
    Shen YC, Zhang WH, Shun LL, et al: A study of renovation rate of dopamine and 5-hydroxytryptamine in brain in chronic schizophrenics. Chinese J Neurol Psychiat 1979;12:158–160.Google Scholar
  34. 34.
    Shen QJ, Ling ZW, Xie GR, et al: Quantitative analysis of 7-aminobutyric acid and glutamic acid in the CSF in schizophrenics. Chinese J Neurol Psychiat 1982:15:98–102.Google Scholar
  35. 35.
    Li E, Song GY, Ling XB, et al: Study on pathogenesis of schizophrenia: Assay of PG and cAMP in CSF and plasma in 25 cases. Chinese J Neurol Psychiat 1987;20:81–83.Google Scholar
  36. 36.
    Wang SB, Chen GF, Zhao BZ, et al: A preliminary study on the measurements of microelements in the serum of schizophrenics. Chinese J Neurol Psychiat 1987;20:217–218.Google Scholar
  37. 37.
    Zhang DR, Huang RG: Pilot study of Mn in hair in schizophrenics. Chinese J Neurol Psychiat 1987;20:187.Google Scholar
  38. 38.
    Huang MS, Liou XH, Dong YH, et al: Preliminary study on platelet monoamine oxidase in schizophrenic patients. Chinese J Neurol Psychiat 1980;13:193–196.Google Scholar
  39. 39.
    Murphy DL, Wyatt RJ: Reduced monoamine oxidase activity in blood platelets from schizophrenic patients. Nature 1972;238:225–226.PubMedCrossRefGoogle Scholar
  40. 40.
    Sun HR: Preliminary studies of platelets monoamine oxidase in chronic schizophrenia. Chinese J Nerv Ment Dis 1982;8:224–226.Google Scholar
  41. 41.
    Kuang PG, Xu B, Dai CL, et al: A study of plasma dopamine-p-hydroxylase activity in patients with schizophrenia. Chinese J Neurol Psychiat 1982;15:193–197.Google Scholar
  42. 42.
    Huang MS, Lion XH, Dong YH, et al: A preliminary study on lactate dehydrogenase and its analogues in schizophrenics. Chinese J Neurol Psychiat 1980;13:154–156.Google Scholar
  43. 43.
    Gu NF, Ying JL, Zhang C, et al: Pharmacokinetic study of clozapine. Chinese J Neurol Psychiat. 1988;21:259–262.Google Scholar
  44. 44.
    Shu L, Shen YC, Zhou DF, et al: Comparison of therapeutic effects between haloperidol and insulin coma for schizophrenia and the optimal blood level of haloperidol. Chinese J Neurol Psychiat 1987;20:43–48.Google Scholar
  45. 45.
    Chen YF, Lu XW: Changes of EEG in 84 schizophrenic patients treated with haloperidol or chlorpromazine. J Electroencephalography Nerv Ment Dis 1988;4:22–23.Google Scholar
  46. 46.
    Jiao HQ, Li SL, Yu SC, et al: Complications in antipsychotic drug treatment. Chinese J Nerv Ment Dis 1981;7:29–31.Google Scholar
  47. 47.
    Xu SH, Zhang YH: Clozapine and agranulocytosis. Chinese J Neurol Psychiat 1984;17:271–272.Google Scholar
  48. 48.
    Zhang LD, Yan WW, Zhang EL, et al: A tardive dyskinesia study of psychiatric inpatients. Chinese J Neurol Psychiat 1988;21:232–235.Google Scholar
  49. 49.
    Jeste DV, Wyatt RJ: Changing epidemiology of tardive dyskinesia. Am J Psychiatry 1981;138:297–309.PubMedCrossRefGoogle Scholar
  50. 50.
    Wang QD, Jiang SD, Feng GC, et al: Preliminary study on NK activity in peripheral blood lymphocytes of schizophrenic patients. Chinese J Neurol Psychiat 1987;20:215–216.Google Scholar
  51. 51.
    Ni CY, Xu H, Xia JZ: A preliminary study on the immunological changes in schizophrenics. Chinese J Neurol Psychiat 1986;19:34–37.Google Scholar
  52. 52.
    Wang WS, Han YZ, Jin H: Autoimmunity in schizophrenic patients. Chinese J Neurol Psychiat 1986;19:332–334.Google Scholar
  53. 53.
    Guo ZH, Zhen GZ, Lu XD, et al: Assay of serum immunoglobulin in 80 cases of schizophrenics. Chinese J Nerv Ment Dis 1985;11:179–180.Google Scholar
  54. 54.
    Wang WS, Jing SZ, Mu CH, et al: Human leukocyte antigen and schizophrenia. Chinese J Neurol Psychiat 1984;17:284–286.Google Scholar
  55. 55.
    Yan JS, Pu Q, Li YL: Positive reaction of serum anti-DNA antibody induced by phenothiazines in schizophrenic patients. Chinese J Neurol Psychiat 1984;17:333–335.Google Scholar
  56. 56.
    Chi ZZ, Jiang SY, Liou XZ, et al: Preliminary observation on changes of T- lymphocytes labelled with non-specific esterase in schizophrenics. Chinese J Neurol Psychiat 1983;16:242–243.Google Scholar
  57. 57.
    Guo ZH, Zheng GZ, Men XD, et al: A controlled study of cerebrospinal fluid immonoglobulins in 54 chronic schizophrenic patients. Chinese J Nerv Ment Dis 1983;9:85–87.Google Scholar
  58. 58.
    Lou WW, Xiao GM, Chen MG: Preliminary study of Serum immunoglobulin in 100 cases of schizophrenia. Chinese J Nerv Ment Dis 1982;8:103.Google Scholar
  59. 59.
    Li LX, Qiou Y, Muo GM: Cellular immunity of schizophrenics. Chinese J Nerv Ment Dis 1982;8:261–263.Google Scholar
  60. 60.
    Weng Z, Li BY, Hou YY, et al: Preliminary study of serum immunological globulin in schizophrenics. Chinese J Nerv Ment Dis 1980;6:260–263.Google Scholar
  61. 61.
    Huo KJ, Yan SJ, Liou XH, et al: Preliminary observations on immunoglobulins in schizophrenics. Chinese J Neurol Psychiat 1979;12:161–163.Google Scholar
  62. 62.
    Qiou Y, Luo ZK, He XQ: Study on serum immunoglobulin in schizophrenia. Chinese J Neurol Psychiat 1979;12:241–242.Google Scholar
  63. 63.
    Gu JS, Xu CL, Yan HQ, et al: Preliminary study on lymphocytic transformation test and intracutaneous tuberculin test in schizophrenics. Chinese J Neurol Psychiat 1979;12:193–195.Google Scholar
  64. 64.
    Gu NF, Zhang MY, Ren FM, et al: A comparative study on the dexamethe- sone suppression test in acute and chronic schizophrenia. Chinese J Neurol Psychiat 1985;18:287–290.Google Scholar
  65. 65.
    Fan MH, Chen GQ, Muo GM: A preliminary report of dexamethasone test in depressive, manic, schizophrenic patients, and control subjects. Chinese J Nerv Ment Dis 1985;11:23–25.Google Scholar
  66. 66.
    Zhang FC, Zhang JF, Wang DN, et al: Study on the effect of antipsychotic drugs on serum prolactin in schizophrenic patients. Chinese J Nerv Ment Dis 1986;12:80–82.Google Scholar
  67. 67.
    Wu EH, Mo BC, Zhuo HY: A study of air encephalography on 384 cases. Chinese J Neurol Psychiat 1960;6:42–44.Google Scholar
  68. 68.
    Yu QH, Chen PZ, Liu TS, et al: Cognitive function and computerized tomography of the brain in deteriorated schizophrenics. Chinese J Neurol Psychiat 1983;16:42–45.Google Scholar
  69. 69.
    Zhang TP, Len JP: CT observations on the morphological changes of the brain in schizophrenics. Chinese J Neurol Psychiat 1985;18:158–161.Google Scholar
  70. 70.
    Wang XY, Li WD, Hu JR, et al: Comparative study of the brain CT scan and clinical manifestation in schizophrenia of 73 cases. Chinese J Nerv Ment Dis 1986;12:345–347.Google Scholar
  71. 71.
    Zhang MD, Xia ZY, Li ZD, et al: A preliminary study of evoked brain potentials on schizophrenics. Chinese J Neurol Psychiat 1983;16:274–277.Google Scholar
  72. 72.
    Zhang MD, Chen XS, Li ZD, et al: A comparative study of evoked potentials on clinical symptoms and treatment effectiveness in acute schizophrenics. Chinese J Neurol Psychiat 1988;21:178–182.Google Scholar
  73. 73.
    Zhang MD, Chen XS, Li ZD, et al: Clinical study of AEP and VEP on acute schizophrenics. Shanghai Arch Psychiat 1987:5:47–51.Google Scholar
  74. 74.
    Xia ZY, Zhang MD, Jiang KD, et al: A clinical study on schizophrenics with contingent negative variation. Chinese J Neurol Psychiat 1983;16:321–324.Google Scholar
  75. 75.
    Hou Y, Di S: A preliminary report on EEG spectrum analysis of schizophrenia. Chinese J Neurol Psychiat 1984;17:129–130.Google Scholar
  76. 76.
    Yang ZJ, Hou Y, Shu L, et al: Computerized analysis of spontaneous EEG in schizophrenics. Chinese J Neurol Psychiat 1987;20:87–91.Google Scholar

Copyright information

© Springer-Verlag New York Inc. 1990

Authors and Affiliations

  • Zhang Mingdao
  • Xia Zhenyi

There are no affiliations available

Personalised recommendations